BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 16490176)

  • 1. Role of rat liver cytochrome P450 3A and 2D in metabolism of imrecoxib.
    Xu HY; Xie ZY; Zhang P; Sun J; Chu FM; Guo ZR; Zhong DF
    Acta Pharmacol Sin; 2006 Mar; 27(3):372-80. PubMed ID: 16490176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of 4'-carboxyl acid metabolite of imrecoxib by rat liver microsomes.
    Xu HY; Zhang P; Gong AS; Sun YM; Chu FM; Guo ZR; Zhong DF
    Acta Pharmacol Sin; 2006 Apr; 27(4):506-12. PubMed ID: 16539853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of enzymes responsible for biotransformation of the new antileukotrienic drug quinlukast in rat liver microsomes and in primary cultures of rat hepatocytes.
    Szotáková B; Skálová L; Baliharová V; Dvorscáková M; Storkánová L; Sispera L; Wsól V
    J Pharm Pharmacol; 2004 Feb; 56(2):205-12. PubMed ID: 15005879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
    Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cytochrome P450 in oxazaphosphorine metabolism. Deactivation via N-dechloroethylation and activation via 4-hydroxylation catalyzed by distinct subsets of rat liver cytochromes P450.
    Yu L; Waxman DJ
    Drug Metab Dispos; 1996 Nov; 24(11):1254-62. PubMed ID: 8937861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The In vitro hepatic metabolism of quinine in mice, rats and dogs: comparison with human liver microsomes.
    Zhao XJ; Ishizaki T
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1168-76. PubMed ID: 9399990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on metabolism of tetramethylpyrazine in system of rat liver microsomes].
    Kuang XD; Li XH; Xiong YQ
    Zhongguo Zhong Yao Za Zhi; 2006 Dec; 31(23):1971-5. PubMed ID: 17348193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.
    Kasahara M; Suzuki H; Komiya I
    Drug Metab Dispos; 2000 Apr; 28(4):409-17. PubMed ID: 10725309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro metabolism of L-696,229, an HIV-1 reverse transcriptase inhibitor in rats and humans. Hepatic and extrahepatic metabolism and identification of enzymes involved in the hepatic metabolism.
    Prueksaritanont T; Dwyer LM; Balani SK; Theoharides AD
    Drug Metab Dispos; 1994; 22(2):281-8. PubMed ID: 7516854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation on the hydroxylation metabolism of imrecoxib in vitro by using recombinant human CYPs].
    Li Q; Huang HH; Dong Y; Zhong DF
    Yao Xue Xue Bao; 2005 Oct; 40(10):912-5. PubMed ID: 16408808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative metabolism of monensin in rat liver microsomes and interactions with tiamulin and other chemotherapeutic agents: evidence for the involvement of cytochrome P-450 3A subfamily.
    Nebbia C; Ceppa L; Dacasto M; Carletti M; Nachtmann C
    Drug Metab Dispos; 1999 Sep; 27(9):1039-44. PubMed ID: 10460804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of metabolites and cytochrome P450 isoforms involved in the microsomal metabolism of aconitine.
    Wang Y; Wang S; Liu Y; Yan L; Dou G; Gao Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Dec; 844(2):292-300. PubMed ID: 16949890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and excretion of imrecoxib in rat.
    Xu H; Zhang Y; Sun Y; Zhang P; Chu F; Guo Z; Zhang H; Zhong D
    Xenobiotica; 2006 May; 36(5):441-55. PubMed ID: 16854781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the In Vivo and In Vitro Metabolism of Imrecoxib in Humans: Formation of the Rate-Limiting Aldehyde Intermediate.
    Hou X; Zhou J; Yu S; Zhou L; Zhang Y; Zhong D; Chen X
    Drug Metab Dispos; 2018 Sep; 46(9):1320-1328. PubMed ID: 29980580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rat liver cytochrome P450 metabolism of N-acetylbenzidine and N,N'-diacetylbenzidine.
    Lakshmi VM; Zenser TV; Davis BB
    Drug Metab Dispos; 1997 Apr; 25(4):481-8. PubMed ID: 9107548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotransformation of the anthraquinones emodin and chrysophanol by cytochrome P450 enzymes. Bioactivation to genotoxic metabolites.
    Mueller SO; Stopper H; Dekant W
    Drug Metab Dispos; 1998 Jun; 26(6):540-6. PubMed ID: 9616189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 mediated bioactivation of methyleugenol to 1'-hydroxymethyleugenol in Fischer 344 rat and human liver microsomes.
    Gardner I; Wakazono H; Bergin P; de Waziers I; Beaune P; Kenna JG; Caldwell J
    Carcinogenesis; 1997 Sep; 18(9):1775-83. PubMed ID: 9328175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taxol metabolism by human liver microsomes: identification of cytochrome P450 isozymes involved in its biotransformation.
    Cresteil T; Monsarrat B; Alvinerie P; Tréluyer JM; Vieira I; Wright M
    Cancer Res; 1994 Jan; 54(2):386-92. PubMed ID: 7903909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genistein metabolism in liver microsomes of Wistar and mutant TR(-)-rats.
    Jäger W; Sartori M; Herzog W; Thalhammer T
    Res Commun Mol Pathol Pharmacol; 1998 Apr; 100(1):105-16. PubMed ID: 9644724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and metabolic inhibition of cilnidipine in human liver microsomes.
    Liu XQ; Zhao Y; Li D; Qian ZY; Wang GJ
    Acta Pharmacol Sin; 2003 Mar; 24(3):263-8. PubMed ID: 12617777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.